What is the difference between a central line and a peripheral intravenous line?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Central Line vs Peripheral IV Line: Key Differences

Central lines terminate in the central circulation (superior vena cava or right atrium), while peripheral IV lines terminate in peripheral veins of the extremities—this fundamental anatomical difference determines their capabilities, risks, and appropriate clinical applications 1.

Anatomical and Physical Characteristics

Peripheral IV Catheters

  • Length: Typically 3-6 cm (standard) or ≥8 cm (long peripheral catheters)
  • Location: Inserted and terminate in peripheral veins, commonly in hand or forearm veins
  • Tip position: Remains in peripheral venous system 1

Central Venous Catheters

  • Length: 15-25 cm (nontunneled CVCs) or >45 cm (PICCs)
  • Insertion sites:
    • Traditional CVCs: Direct puncture of internal jugular, subclavian, or femoral veins 1
    • PICCs: Inserted through peripheral arm veins but advanced centrally
  • Tip position: Lower superior vena cava or upper right atrium 1

Clinical Capabilities and Indications

What Peripheral IVs CAN Do:

  • Short-term fluid administration
  • Non-irritant medications
  • Emergency access 2
  • Typical duration: 2-3 days before requiring replacement 3

What Peripheral IVs CANNOT Do:

  • Vesicant or irritant infusions (chemotherapy, parenteral nutrition, high-osmolarity solutions)
  • Reliable long-term access (>5 days)
  • High-flow contrast injection (unless specifically designed power-injectable devices)
  • Frequent blood sampling 4, 2

What Central Lines Enable:

  • Hypertonic, irritant, or vasoconstrictor solutions 2
  • Parenteral nutrition and chemotherapy 1
  • Long-term IV therapy (weeks to months)
  • Reliable venous access when peripheral access fails
  • Central venous pressure monitoring
  • Rapid drug delivery during resuscitation 5
  • Frequent blood sampling 6

Complication Profiles: Critical Differences

Peripheral IV Complications

  • Phlebitis: 14 times more common than with central lines (353/1,024 vs 18/713) 3
  • Infiltration and extravasation
  • Requires frequent replacement (mean 2.9 days) 3
  • Lower infection risk overall
  • No pneumothorax risk

Central Line Complications

  • Insertion risks: Pneumothorax (7/713 insertions), hemothorax, arterial puncture 3
  • Catheter-related bloodstream infection (CRBSI): Higher risk than peripheral IVs
  • Thrombosis: Symptomatic catheter-related thrombosis
  • Longer functional duration (mean 6.2 days for CVCs) 3
  • Overall lower morbidity in critically ill patients despite insertion risks 3

Decision-Making Algorithm

Use Peripheral IV when:

  • Duration ≤5 days anticipated
  • Non-irritant medications only
  • Adequate peripheral venous access available
  • No need for frequent blood sampling

Use Central Line when:

  • Duration >5 days anticipated 4
  • Vesicant/irritant infusions required (chemotherapy, parenteral nutrition, high-osmolarity solutions) 1, 4
  • Peripheral access inadequate or failed
  • Frequent blood sampling needed
  • Critical illness requiring reliable access 3
  • Vasoactive medications required 2

Important Caveats

Midline catheters (7.5-25 cm) represent an intermediate option—inserted peripherally with tip in basilic/cephalic vein but cannot accommodate irritant or vesicant infusions 1. Recent evidence shows midlines have higher complication rates than PICCs for medium-term therapy 7, 8.

Supervision matters: Central line complication rates are highly dependent on insertion technique quality. Pneumothorax can often be managed with simple aspiration rather than chest tube if recognized early 3.

Drug administration timing: During CPR, central venous administration achieves therapeutic levels significantly faster (mean 11 seconds to half-peak vs 84 seconds peripherally), supporting preferential central access in resuscitation 5.

Vein preservation: The 2025 Association of Anaesthetists guidelines emphasize coordinated effort to preserve long-term vein health, with appropriate device selection being central to vascular access services 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.